EPTIS
BAM Logo

AP – Antithrombotic Agents

[AP – Antitrombotické přípravky]

EPTIS factsheet 663184 | Last revision 2020-03-26 | URL: https://www.eptis.bam.de/pts663184 https://www.eptis.bam.de/pts663184

PT provider
PT provider SEKK SEKK
Based in Czech Republic
Language(s) English, Czech
Remarks Complete EQA Plan is available here: http://www.sekk.cz/eqa/EQA_1.htm
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
plasma, for each tests group 1 set containing 2 lyophilised samples of about 1 mL each Group 1 - Apixaban -
Group 2 - Dabigatran -
Group 3 - Rivaroxaban -
Aims of the PT scheme
Target group of participants medical laboratories
Linked to specific legislation / standards ISO 17043
Additional, subsidiary aims
Number of participants 40
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee One EQA round without samples - 26€, Set of samples (each group) - 28€, transport
Regularly operated Yes (2 round per year)
Year of first operation 2018
Contact details of the PT provider
Provider Contact person
SEKK
B35
53001 Pardubice
Czech Republic

Phone: +420 466530230
Fax:
Web: http://www.sekk.cz http://www.sekk.cz
Ing. Marek Budina
Phone: +420 466530230
Fax:
Email: sekk@sekk.cz sekk@sekk.cz
If you find any mistakes please contact the responsible EPTIS coordinator in Czech Republic, Ms Simona Klenovská. Ms Simona Klenovská.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21